Orally Inhaled Insulin
(Source: viralglobalnews.com)
The diabetes industry caters to nearly 10% of the US populations, for a total of 29-million people. That’s just in the USA, not including the 27.8% estimated living with the disease unaware of their illness. With the invention of Afrezza, a pocket-sized inhaler, insulin injection may be a thing of the past. MannKind is the name of the company who invented Afrezza. The inhalers have already been in the hands of clinicians and their patients since 2015. It’s a slow merging into an industry so entrenched in a process that works for the most part, but with time we could see the end of needles. 2017 could be the year you or someone you love stops buying them.
